申请人:Bakthavatchalam Rajagopal
公开号:US20060111337A1
公开(公告)日:2006-05-25
Substituted biaryl quinolin-4-ylamine analogues of Formula I are provided.
Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using such compounds to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.
本发明提供了公式I的取代双芳基喹啉-4-胺类似物。这些化合物是配体,可用于体内或体外调节特定受体活性,并在治疗与人类、家畜伴侣动物和畜牧动物的病理性受体激活相关的疾病方面特别有用。本发明还提供了用于治疗此类疾病的制药组合物和方法,以及用于受体定位研究的这些配体的方法。